Denmeade SR - Search Results

1

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.

Antonarakis ES, Lu C, Luber B, Wang H, Chen Y, Nakazawa M, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J. Antonarakis ES, et al. Among authors: denmeade sr. JAMA Oncol. 2015 Aug;1(5):582-91. doi: 10.1001/jamaoncol.2015.1341. JAMA Oncol. 2015. PMID: 26181238 Free PMC article.

2

Complete androgen blockade for prostate cancer: what went wrong?

Laufer M, Denmeade SR, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: denmeade sr. J Urol. 2000 Jul;164(1):3-9. J Urol. 2000. PMID: 10840412 Free article. Review.

3

In vivo activity of a PSA-activated doxorubicin prodrug against PSA-producing human prostate cancer xenografts.

Khan SR, Denmeade SR. Khan SR, et al. Among authors: denmeade sr. Prostate. 2000 Sep 15;45(1):80-3. doi: 10.1002/1097-0045(20000915)45:1<80::aid-pros10>3.0.co;2-q. Prostate. 2000. PMID: 10960846

4

A history of prostate cancer treatment.

Denmeade SR, Isaacs JT. Denmeade SR, et al. Nat Rev Cancer. 2002 May;2(5):389-96. doi: 10.1038/nrc801. Nat Rev Cancer. 2002. PMID: 12044015 Free PMC article. Review.

5

A phase II trial of temozolomide and IFN-alpha in patients with advanced renal cell carcinoma.

Sunkara U, Walczak JR, Summerson L, Rogers T, Eisenberger M, Denmeade S, Pili R, Huff CA, Sinibaldi V, Carducci MA. Sunkara U, et al. J Interferon Cytokine Res. 2004 Jan;24(1):37-41. doi: 10.1089/107999004772719891. J Interferon Cytokine Res. 2004. PMID: 14980083 Clinical Trial.

6

Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma.

Sinibaldi VJ, Elza-Brown K, Schmidt J, Eisenberger MA, Rosenbaum E, Denmeade SR, Pili R, Walczak J, Baker SD, Zahurak M, Carducci MA. Sinibaldi VJ, et al. Among authors: denmeade sr. Am J Clin Oncol. 2006 Aug;29(4):395-8. doi: 10.1097/01.coc.0000225411.95479.b4. Am J Clin Oncol. 2006. PMID: 16891869 Clinical Trial.

7

Combinatorial androgen receptor targeted therapy for prostate cancer.

Singh P, Uzgare A, Litvinov I, Denmeade SR, Isaacs JT. Singh P, et al. Among authors: denmeade sr. Endocr Relat Cancer. 2006 Sep;13(3):653-66. doi: 10.1677/erc.1.00797. Endocr Relat Cancer. 2006. PMID: 16954423 Review.

8

Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy.

Bajaj GK, Zhang Z, Garrett-Mayer E, Drew R, Sinibaldi V, Pili R, Denmeade SR, Carducci MA, Eisenberger MA, DeWeese TL. Bajaj GK, et al. Among authors: denmeade sr. Urology. 2007 Mar;69(3):526-31. doi: 10.1016/j.urology.2006.12.006. Urology. 2007. PMID: 17382158 Clinical Trial.

9

Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint.

Collins C, Carducci MA, Eisenberger MA, Isaacs JT, Partin AW, Pili R, Sinibaldi VJ, Walczak JS, Denmeade SR. Collins C, et al. Among authors: denmeade sr. Cancer Biol Ther. 2007 Sep;6(9):1360-7. doi: 10.4161/cbt.6.9.4541. Epub 2007 Jun 5. Cancer Biol Ther. 2007. PMID: 17786033 Free PMC article.

10

The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin.

Kachhap SK, Faith D, Qian DZ, Shabbeer S, Galloway NL, Pili R, Denmeade SR, DeMarzo AM, Carducci MA. Kachhap SK, et al. Among authors: denmeade sr. PLoS One. 2007 Sep 5;2(9):e844. doi: 10.1371/journal.pone.0000844. PLoS One. 2007. PMID: 17786215 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page